vs
Side-by-side financial comparison of GYRE THERAPEUTICS, INC. (GYRE) and SANDRIDGE ENERGY INC (SD). Click either name above to swap in a different company.
SANDRIDGE ENERGY INC is the larger business by last-quarter revenue ($39.4M vs $37.2M, roughly 1.1× GYRE THERAPEUTICS, INC.). SANDRIDGE ENERGY INC runs the higher net margin — 54.9% vs -3.7%, a 58.6% gap on every dollar of revenue. On growth, GYRE THERAPEUTICS, INC. posted the faster year-over-year revenue change (33.4% vs 1.1%). SANDRIDGE ENERGY INC produced more free cash flow last quarter ($14.4M vs $-5.8M). Over the past eight quarters, GYRE THERAPEUTICS, INC.'s revenue compounded faster (17.0% CAGR vs 14.1%).
GYRE Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel targeted therapies for hard-to-treat hematologic malignancies and solid tumors. It focuses on precision oncology to address unmet patient needs, with operations primarily based in North America.
SandRidge Energy, Inc. is a company engaged in hydrocarbon exploration in the Mid-Continent region of the United States. It is organized in Delaware and headquartered in Oklahoma City, Oklahoma.
GYRE vs SD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $37.2M | $39.4M |
| Net Profit | $-1.4M | $21.6M |
| Gross Margin | 95.3% | — |
| Operating Margin | 0.3% | 38.5% |
| Net Margin | -3.7% | 54.9% |
| Revenue YoY | 33.4% | 1.1% |
| Net Profit YoY | -340.1% | 23.1% |
| EPS (diluted) | $-0.01 | $0.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $37.2M | $39.4M | ||
| Q3 25 | $30.6M | $39.8M | ||
| Q2 25 | $26.8M | $34.5M | ||
| Q1 25 | $22.1M | $42.6M | ||
| Q4 24 | $27.9M | $39.0M | ||
| Q3 24 | $25.5M | $30.1M | ||
| Q2 24 | $25.2M | $26.0M | ||
| Q1 24 | $27.2M | $30.3M |
| Q4 25 | $-1.4M | $21.6M | ||
| Q3 25 | $5.9M | $16.0M | ||
| Q2 25 | $1.6M | $19.6M | ||
| Q1 25 | $3.7M | $13.0M | ||
| Q4 24 | $569.0K | $17.6M | ||
| Q3 24 | $2.9M | $25.5M | ||
| Q2 24 | $4.5M | $8.8M | ||
| Q1 24 | $9.9M | $11.1M |
| Q4 25 | 95.3% | — | ||
| Q3 25 | 94.7% | — | ||
| Q2 25 | 95.7% | — | ||
| Q1 25 | 95.9% | — | ||
| Q4 24 | 95.8% | — | ||
| Q3 24 | 96.2% | — | ||
| Q2 24 | 96.9% | — | ||
| Q1 24 | 96.4% | — |
| Q4 25 | 0.3% | 38.5% | ||
| Q3 25 | 22.7% | 37.8% | ||
| Q2 25 | 8.1% | 53.7% | ||
| Q1 25 | 10.3% | 28.6% | ||
| Q4 24 | 2.4% | 25.9% | ||
| Q3 24 | 16.6% | 28.3% | ||
| Q2 24 | 12.7% | 23.9% | ||
| Q1 24 | 29.7% | 27.8% |
| Q4 25 | -3.7% | 54.9% | ||
| Q3 25 | 19.4% | 40.1% | ||
| Q2 25 | 5.9% | 56.6% | ||
| Q1 25 | 16.9% | 30.6% | ||
| Q4 24 | 2.0% | 45.1% | ||
| Q3 24 | 11.2% | 84.8% | ||
| Q2 24 | 18.0% | 33.9% | ||
| Q1 24 | 36.6% | 36.7% |
| Q4 25 | $-0.01 | $0.59 | ||
| Q3 25 | $0.03 | $0.43 | ||
| Q2 25 | $0.00 | $0.53 | ||
| Q1 25 | $0.00 | $0.35 | ||
| Q4 24 | $0.00 | $0.46 | ||
| Q3 24 | $0.01 | $0.69 | ||
| Q2 24 | $0.01 | $0.24 | ||
| Q1 24 | $0.03 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.4M | $111.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $106.0M | $510.9M |
| Total Assets | $166.1M | $644.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.4M | $111.0M | ||
| Q3 25 | $60.0M | $101.2M | ||
| Q2 25 | $54.4M | $102.8M | ||
| Q1 25 | $29.9M | $99.7M | ||
| Q4 24 | $26.7M | $98.1M | ||
| Q3 24 | $25.1M | $92.7M | ||
| Q2 24 | $25.1M | $209.9M | ||
| Q1 24 | $37.4M | $207.0M |
| Q4 25 | $106.0M | $510.9M | ||
| Q3 25 | $101.9M | $492.4M | ||
| Q2 25 | $92.0M | $480.2M | ||
| Q1 25 | $68.1M | $464.9M | ||
| Q4 24 | $63.3M | $460.5M | ||
| Q3 24 | $63.2M | $446.8M | ||
| Q2 24 | $60.4M | $424.8M | ||
| Q1 24 | $56.6M | $419.7M |
| Q4 25 | $166.1M | $644.0M | ||
| Q3 25 | $159.4M | $619.0M | ||
| Q2 25 | $152.6M | $602.3M | ||
| Q1 25 | $129.8M | $588.3M | ||
| Q4 24 | $125.4M | $581.5M | ||
| Q3 24 | $125.2M | $565.2M | ||
| Q2 24 | $120.9M | $529.6M | ||
| Q1 24 | $122.0M | $527.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.6M | $31.7M |
| Free Cash FlowOCF − Capex | $-5.8M | $14.4M |
| FCF MarginFCF / Revenue | -15.5% | 36.6% |
| Capex IntensityCapex / Revenue | 0.4% | 43.8% |
| Cash ConversionOCF / Net Profit | — | 1.46× |
| TTM Free Cash FlowTrailing 4 quarters | $-180.0K | $41.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.6M | $31.7M | ||
| Q3 25 | $4.7M | $25.3M | ||
| Q2 25 | $2.1M | $22.9M | ||
| Q1 25 | $-129.0K | $20.3M | ||
| Q4 24 | $-2.8M | $26.0M | ||
| Q3 24 | $1.7M | $20.8M | ||
| Q2 24 | $-5.5M | $11.4M | ||
| Q1 24 | $2.9M | $15.7M |
| Q4 25 | $-5.8M | $14.4M | ||
| Q3 25 | $4.0M | $5.9M | ||
| Q2 25 | $1.8M | $7.3M | ||
| Q1 25 | $-251.0K | $13.9M | ||
| Q4 24 | $-2.8M | $13.2M | ||
| Q3 24 | $1.0M | $10.8M | ||
| Q2 24 | $-6.9M | $9.0M | ||
| Q1 24 | $2.7M | $14.6M |
| Q4 25 | -15.5% | 36.6% | ||
| Q3 25 | 13.1% | 14.9% | ||
| Q2 25 | 6.8% | 21.0% | ||
| Q1 25 | -1.1% | 32.7% | ||
| Q4 24 | -10.1% | 33.8% | ||
| Q3 24 | 4.1% | 36.1% | ||
| Q2 24 | -27.5% | 34.5% | ||
| Q1 24 | 9.8% | 48.1% |
| Q4 25 | 0.4% | 43.8% | ||
| Q3 25 | 2.2% | 48.6% | ||
| Q2 25 | 1.0% | 45.2% | ||
| Q1 25 | 0.6% | 15.0% | ||
| Q4 24 | 0.2% | 32.9% | ||
| Q3 24 | 2.7% | 33.3% | ||
| Q2 24 | 5.8% | 9.4% | ||
| Q1 24 | 0.9% | 3.7% |
| Q4 25 | — | 1.46× | ||
| Q3 25 | 0.79× | 1.58× | ||
| Q2 25 | 1.32× | 1.17× | ||
| Q1 25 | -0.03× | 1.56× | ||
| Q4 24 | -4.85× | 1.48× | ||
| Q3 24 | 0.60× | 0.82× | ||
| Q2 24 | -1.21× | 1.30× | ||
| Q1 24 | 0.29× | 1.41× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GYRE
Segment breakdown not available.
SD
| Oil Reserves | $19.0M | 48% |
| Natural Gas Reserves | $11.6M | 30% |
| Natural Gas Liquids Reserves | $8.7M | 22% |
